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Abstract
Lactobacillus species, present in the microbiota of breast milk, is a probiotic that deserves 
significant attention. It has a beneficial effect on the composition of the intestinal micro-
flora and the intestinal immune system. In infants who were having Lactobacillus fer-
mentum, a lower incidence of gastrointestinal and respiratory infections was noticed, in 
contrast to the control group. The significant anti-inflammatory effect of L. fermentum can 
be utilized to prevent and treat mastitis in breastfeeding women. It has also been shown 
to have a better clinical effect than classic antibiotics. Moreover, the higher share of  
L. fermentum in intestinal microflora of children with normal weight compared to obese 
ones opens other potential possibilities of the use of this probiotic.
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1. Introduction
Microbiota is a substantial collection of genetic and bioactive materials responsible for build-
ing and regulating our defense systems. Bacteria and their intestinal microbial proportions 
modulate the immune system, greatly affecting the health and illness of an individual. 
Gastrointestinal flora is in close and continuous contact with epithelial and immune cells. This 
constant stimulation is essential for the development and functioning of the immune system 
[1]. These types of bacteria that colonize the guts of a newborn determine how the system 
develops, acting as an important antigenic stimulus for developing the immune response.
In the last 20 years, probiotics, bifidobacteria, Lactobacilli, microorganisms, and gastroin-
testinal flora, all of which can modulate the aspects of both natural and acquired immune 
responses in the host and thus affect human health, have become of prime importance. This 
importance is, of course, widely emphasized commercially. However, the actual effects and 
actions of individual probiotic strains vary, and it is very important to know what specific 
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probiotics are considered in order to determine their effects. Bacteria colonize vast areas of 
the mucous membranes and they are also present in important body fluids like breast milk. 
The mother’s vaginal flora and breast milk are clearly among the most important sources of 
bacteria for the newborn. Varying studies have reported differing quantities of live bacteria in 
breast milk, but most studies report median numbers of 102–103 and a range of 101–107 colony 
forming units per ml of breast milk [2]. The infant who receives 300–700 ml of milk per day 
receives a large amount of these bacteria at the same time. The microbiota of milk, like that of 
mucous membranes, is individual and changeable. The probiotic bacteria present in mucous 
membranes and breast milk includes Lactobacillus fermentum. The expected pathway by which 
Lactobacilli is received into the milk is enteromammary transport through the dendritic cells 
[3]. This type of transport is still a controversial subject; however, various studies suggest that 
dendritic cells can pick up bacteria located in the intestinal lumen and transfer them to the 
lamina propria. Once the bacteria get inside the dendritic cells, they can penetrate the mam-
mary glands and other mucosal surfaces.
2. Lactobacillus species and infectious diseases of infants
Respiratory and gastrointestinal tract infections are a significant problem for young children 
attending daycare centers or preschool, especially in the winter season. Common infectious 
diseases are facilitated by a general immaturity of the immune system and of the respiratory 
and gastrointestinal tract function [4]. An increased number of acute diseases translate into a 
significant financial burden for both the family and society. The increased costs are related to 
medical care visits and medication as well as to time away from work and/or for payment for 
someone to look after a sick child [5].
The most widely used probiotic species, which belong to the genera Lactobacillus and 
Bifidobacterium, have shown clinically significant benefits in the treatment and prevention of 
childhood diarrheal and allergic diseases in at-risk populations such as allergic families, hos-
pitalized patients, or children in daycare centers. In a study in which Lactobacillus reuteri was 
administered for 3 months in 336 otherwise healthy children attending daycare centers, it was 
shown that during the administration and for the next 3 months, the number of episodes of 
diarrhea has significantly decreased [6]. The effects of probiotics in preventing respiratory 
tract infections are also receiving increasing attention. In accordance with the same study 
mentioned earlier, the number of respiratory tract infections in the 336 children has also sig-
nificantly decreased at 3 and 6 months after the administration of the probiotics [6]. There 
are many sources of confusion concerning probiotic intervention in children. First, the mode 
of probiotic administration in the general child population is challenging. Second, the selec-
tion of a specific probiotic strain or a probiotic mixture is crucial for the possible beneficial 
effects. The duration of breastfeeding and the use of infant formula also affect the outcome 
[7]. Several clinical studies have been carried out to investigate bacteria isolated from human 
milk. In a 6-month study [8] with 91 infants in the control group and 97 infants in the L. fer-
mentum group, a reduction in the total number of infections, especially gastrointestinal tract 
and respiratory infections, was observed in the probiotics group (Table 1). L. fermentum was 
selected for the study for safety and for its anti-infective and immunomodulatory properties.
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This strain is also able to colonize the mammary glands when administered to nursing mothers 
in capsule form. A similar effect on the health of children has been described in other probiotic 
strains. A multicenter, randomized, double-blind, placebo-controlled trial [4] on 126 healthy 
children aged 12–48 months with Lactobacillus paracasei (66 infants in the experimental group 
and 60 infants in the placebo group) showed a lower incidence of respiratory and gastrointesti-
nal tract infections in the experimental group than in the control group (Table 2). An immuno-
stimulatory effect was observed, consisting of a significant increase in the production of innate 
and acquired immunity peptides. Innate immunity peptides, produced by epithelial cells, 
Paneth cells, neutrophils, and macrophages, act as endogenous antimicrobial substances and 
defend the body against a broad range of pathogens (bacteria, fungi, protozoa, and viruses).
Another bacterium isolated from breast milk that has a positive effect on diseases in infants 
and children is L. reuteri. The mechanism of action of L. reuteri strains has been evaluated in 
in vitro and animal studies. One of the best-documented mechanisms is their antimicrobial 
activity. L. reuteri strains produce reuterin, a broad-spectrum antibacterial substance that can 
Control group Experimental group Incidence rate decrease (%)
Total infections 189 142 30
Gastrointestinal infections 33 19 46
Respiratory infections 134 106 26
• Upper respiratory 121 94 27
• Lower respiratory 13 12 13
Table 1. Lactobacillus fermentum administered to 6-month-old infants over a 6-month period versus Lactobacilli-free 
control group [8].
Disease Control group Experimental group p
Acute gastroenteritis, n (%)
(number of episodes)
24 (40.0)
(28)
12 (18.2)
(19)
0.007
Rhinitis, n (%)
(number of episodes)
24 (40.0)
(50)
22 (33.3)
(44)
0.438
Otitis media, n (%)
(number of episodes)
13 (21.7)
(17)
8 (12.1)
(11)
0.151
Pharyngitis, n (%)
(number of episodes)
25 (41.7)
(30)
13 (19.7)
(22)
0.007
Laryngitis, n (%)
(number of episodes)
14 (23.3)
(14)
6 (9.1)
(7)
0.029
Tracheitis, n (%)
(number of episodes)
19 (31.7)
(30)
11 (16.7)
(16)
0.048
Table 2. Common infectious diseases observed during the study period [4].
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inhibit the growth of a wide spectrum of microorganisms such as Gram-positive or -negative 
bacteria, yeast, fungi, and parasites. L. reuteri strains may also regulate immune response. The 
results of 14 studies involving controlled trials and one systematic review indicate that the 
use of L. reuteri may be considered in the management of acute gastroenteritis as an adjunct to 
rehydration. There is also some evidence that L. reuteri is effective in reducing the incidence 
of diarrhea in children attending daycare centers [9]. Lactobacillus rhamnosus, a probiotic strain 
of human origin, also influences immune response both specifically by stimulating antibody 
production and non-specifically by enhancing the phagocytic activity of the blood leucocytes. 
It can promote the recovery from rotavirus diarrhea and can reduce the incidence of diar-
rhea associated with the use of antibiotics. In a randomized, double-blind, placebo-controlled 
study with 571 healthy children aged 1–6 years, there was a 17% relative reduction in the 
number of children with respiratory infections with complications and lower respiratory tract 
infections and a 19% relative reduction in antibiotic treatments for respiratory infection [10].
3. L. fermentum in the treatment of mastitis
Mastitis is a common disease during lactation, affecting 3–33% of lactating mothers. 
Inflammation of the mammary glands usually has an infectious origin involving staphylo-
cocci, streptococci, and/or Corynebacterium. Traditionally, Staphylococcus aureus has been 
considered the main etiological agent of acute mastitis, although Staphylococcus epidermidis 
is emerging as the leading cause of chronic mastitis. Multidrug resistance and/or the forma-
tion of biofilms are very common among clinical isolates of these two staphylococcal species. 
This explains why mastitis is difficult to treat with antibiotics and why it constitutes one of 
the main reasons to cease breastfeeding. In this context, the development of new strategies 
based on probiotics, as alternatives or complements to antibiotic therapy for the management 
of mastitis, is particularly appealing. The anti-inflammatory effect of L. fermentum can be suc-
cessfully used to prevent and treat mastitis in a breastfeeding woman. Given as a nutritional 
supplement to a woman with breast inflammation, it demonstrated a better clinical effect 
than conventional antibiotics. Moreover, a higher proportion of L. fermentum in breast milk is 
beneficial to the child by favorably modulating the child’s intestinal microflora, with benefi-
cial consequences for the immune system and health. A study [11] of 352 women with symp-
toms of mastitis demonstrated a beneficial effect of treatment with lactobacilli. The women 
were divided into three different groups: one group using L. fermentum and one group using 
Lactobacillus salivarius, both strains isolated from human milk and a third group receiving 
antibiotics. After 21 days, a reduction in the number of the main etiological agents causing 
mastitis (S. epidermidis, S. aureus, and Streptococcus mitis) was observed. This reduction was 
greater in the probiotic groups (Figure 1). The groups in which Lactobacilli were used also 
experienced greater pain reduction (Figure 2). A similar study of 225 women with severe 
mastitis caused by staphylococci demonstrated a beneficial effect of L. fermentum treatment. 
There was a faster retreat than in the control group treated with antibiotics. Mastitis relapse 
was more common among the women treated with antibiotics (31% versus 10%). The prin-
ciple of the antibacterial action of L. fermentum could be explained by its high ability to adhere 
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to epithelial cells and inhibit the adhesion of pathogenic bacteria by producing antimicrobial 
compounds (lactic acid, H2O2) and by its effect on increased mucin production. The action of 
L. fermentum is immunostimulatory.
4. Individually different microflora of normal-weight and obese 
individuals and the role of probiotics
Obesity is viewed as one of the more important public health problems of our time, and the 
velocity of propagation is highest in children. This can lead to a vicious circle: obese children 
often become obese adults, and maternal obesity overnourishes the fetus, thereby program-
ming adult size and health with a heightened risk of obesity later in life. Recent scientific 
Figure 1. Bacterial counts from breast milk at the beginning (day 0) and at the end (day 21) of the trial [11].
Figure 2. Breast pain score at the beginning (day 0) and at the end (day 21) of the trial. Pain is expressed as extremely 
painful (0) to no pain (10) [11].
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advances point to systemic low-grade inflammation and local gut microbiota as contributing 
factors for overnutrition. The gut microbiota enables the hydrolysis of indigestible polysac-
charides into easily absorbable monosaccharides and the activation of lipoprotein lipase by 
direct action on the villous epithelium. Consequently, glucose is rapidly absorbed and fatty 
acids are excessively stored, with both processes boosting weight gain.
Bacterial milk composition in obese mothers differs from the bacterial milk composition of 
mothers with standard body weight [11]. Since breast milk is one of the most important means 
of colonizing infants with bacteria, there is an idea that there is a relationship between obesity 
and the transmission of microbial flora from mother to infant. It is known that obese infants 
and obese children generally have very different microbial flora from infants who are lean and 
healthy (Figure 3). The results reported by Kalliomäki et al. suggested that gut microbiota devi-
ations predispose individuals toward energy storage and obesity. The genus Bifidobacterium, 
affecting both the quantity and quality of the microbiota during the first year of life, was shown 
to be higher in children who remained normal weight than in children developing overweight. 
The microbiota aberrancy during infancy in children becoming overweight was also associated 
with a greater number of S. aureus than in children remaining normal weight as assessed by 
real-time qRT-PCR. These findings imply that high numbers of probiotics and low numbers 
of S. aureus in infancy may provide protection against overweight and obesity development.
Perhaps it would be advisable to think about intervention in cases of obese mothers. When is the 
right time for such an intervention? We know that some bacteria are transmitted from mother 
to infant. For an obese mother, it would be most helpful to choose an appropriate intervention 
before or during pregnancy, in any case before giving birth. If the microbial flora has already 
been transferred to the infant, it could be optimized during breastfeeding through specific pro-
biotics. L. fermentum, a strain isolated directly from breast milk in the form of a food supplement, 
is available as a possible solution. Whether the expected effect of normalization of the intestinal 
microflora can be produced by such a solution should be confirmed by further studies.
Figure 3. Bacterial counts in fecal samples analyzed by fluorescent in situ hybridization during infancy (6–12 months) [12].
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5. The effect of probiotics deserves further clinical trials
The mucosal microbiota is formed by millions of bacteria. The Lactobacillus species are 
undoubtedly important bacteria for the development of humoral and cellular immunity. 
However, in the human gut, they are only a part of a huge mosaic where each particle has its 
place and function. After decades of research, probiotics are still an open chapter of great and 
unimagined opportunities to influence the immune system and to treat some of civilization’s 
diseases. Most of these diseases are multifactorial. Influencing the mucosal microflora seems 
to be a promising step. Available data suggest that some probiotics such as L. fermentum, 
L. reuteri, L. paracasei, and L. rhamnosus may have some effect on community-acquired infec-
tions; however, confirmation studies are still needed.
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